This Article Full Text Full Text (PDF) All Versions of this Article: 98/1/149    most recent 01.RES.0000199295.14073.69v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Woollard, K.J. Articles by Chin-Dusting, J. Search for Related Content PubMed PubMed Citation Articles by Woollard, K.J. Articles by Chin-Dusting, J. Related Collections Platelets Mechanism of atherosclerosis/growth factors Pathophysiology Cell biology/structural biology Cell signalling/signal transduction Related Article

(Circulation Research. 2006;98:149.)
© 2006 American Heart Association, Inc.

Clinical Research

Raised Plasma Soluble P-Selectin in Peripheral Arterial Occlusive Disease Enhances Leukocyte Adhesion

K.J. Woollard, D. Kling, S. Kulkarni, A.M. Dart, S. Jackson^*, J. Chin-Dusting^*

From Alfred and Baker Medical Unit (K.J.W., A.M.D., J.C.-D.), Wynn Domain, Baker Heart Research Institute, Melbourne, Australia; Australian Centre for Blood Disease (S.K., S.J.), Monash University, Melbourne, Australia; F-Hoffman La Roche (D.K.), Basel, Switzerland.

Correspondence to K. J. Woollard, Baker Heart Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, 8008, Australia. E-mail Kevin.Woollard{at}baker.edu.au

Raised levels of soluble P-selectin (sP-selectin) have been reported in the plasma of patients with vascular diseases; however, the functional importance of this ligand remains unclear. In this study we have examined a potential role for plasma sP-selectin in regulating neutrophil adhesion in patients with peripheral arterial occlusive disease (PAOD). Patients with PAOD had significantly higher levels of sP-selectin (mean±SD: 73.3±13.0 versus 16.7±6.4 ng/mL) and enhanced whole blood leukocyte adhesion to platelets under shear. To examine whether the raised sP-selectin levels can directly influence leukocyte adhesion, isolated neutrophils were incubated with plasma from PAOD patients before and after immunodepletion of sP-selectin. Neutrophil adhesion to fibrinogen increased 2-fold following incubation with PAOD plasma, which was abrogated on sP-selectin immunodepletion. We subsequently demonstrated that recombinant sP-selectin dose-dependently (75 to 250 ng/mL) increased leukocyte adhesion to fibrinogen and platelet monolayers. This increase was PSGL-1 and Src kinase-dependent and correlated with an increase in sP-selectin-mediated Mac-1 activation. sP-selectin–stimulated neutrophil adhesion to platelet monolayers was inversely correlated with shear, such that at low shear (50 s^–1) a 92.7%±15.7 increase in adhesion was observed decreasing to 38.5%±11.9 at 150 s^–1 and 10.1%±7.4 at 300 s^–1. These studies suggest a potentially important role for sP-selectin in modulating neutrophil adhesion in patients with PAOD, particularly at sites of low shear, where it raises the possibility that raised plasma sP-selectin levels may enhance leukocyte recruitment to vascular injury and promote disease progression.

Key Words: atherosclerosis • cell adhesion molecules • leukocytes • peripheral vascular disease

Related Article:

Double Jeopardy: How Soluble P-Selectin Activates Leukocytes in Peripheral Arterial Occlusive Disease

Elena Galkina and Klaus Ley
Circ. Res. 2006 98: 12-14. [Full Text] [PDF]

This article has been cited by other articles:

				D. D. Wagner and P. S. Frenette The vessel wall and its interactions Blood, June 1, 2008; 111(11): 5271 - 5281. [Abstract] [Full Text] [PDF]

				R. M. Rao, L. Yang, G. Garcia-Cardena, and F. W. Luscinskas Endothelial-Dependent Mechanisms of Leukocyte Recruitment to the Vascular Wall Circ. Res., August 3, 2007; 101(3): 234 - 247. [Abstract] [Full Text] [PDF]

				E. Galkina and K. Ley Double Jeopardy: How Soluble P-Selectin Activates Leukocytes in Peripheral Arterial Occlusive Disease Circ. Res., January 6, 2006; 98(1): 12 - 14. [Full Text] [PDF]